Squamous cell carcinoma of the oral cavity+1
Not yet recruitingStudy of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma
Study of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma
- Disease:Squamous cell carcinoma of the oral cavityLip and/or oral cavity cancer
- Substances:IpilimumabNivolumab
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Ipilimumab
- Sponsor:Amsterdam UMC Stichting









